STOCK TITAN

Genix Pharmaceut Stock Price, News & Analysis

GENPF OTC Link

Company Description

Genix Pharmaceuticals Corporation (GENPF) is a pioneering player in the ophthalmic drugs industry. Specializing in novel and generic products, the company excels in research, development, and distribution of evidence-based healthcare solutions. With a strong focus on proprietary OTC nutraceuticals and single molecule generic drugs, Genix aims to deliver consistent and effective results across various therapeutic areas. The company's global presence extends to markets in Canada and beyond, catering to the health needs of mainstream consumers. Through ongoing R&D efforts, Genix remains committed to innovation and excellence in the pharmaceutical sector.

Stock Performance

$—
0.00%
0.00
Last updated:
-
Performance 1 year

SEC Filings

No SEC filings available for Genix Pharmaceut.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

SEP
04
September 4, 2027 Financial

Warrant expiration

Transferable warrants expire allowing purchase at $0.10 per share
SEP
04
September 4, 2027 Financial

Warrant expiration

Expiry of transferable warrants exercisable at C$0.10 per share

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Genix Pharmaceut (GENPF)?

The current stock price of Genix Pharmaceut (GENPF) is $0.0138 as of July 3, 2025.

What is the market cap of Genix Pharmaceut (GENPF)?

The market cap of Genix Pharmaceut (GENPF) is approximately 1.3M. Learn more about what market capitalization means .

What is Genix Pharmaceuticals Corporation known for?

Genix is a leading player in the ophthalmic drugs industry, specializing in novel and generic healthcare products.

Where does Genix market and sell its products?

Genix markets its portfolio of ophthalmic drugs globally and nutraceutical products in North America and select countries.

What is the focus of Genix's research and development efforts?

Genix focuses on developing evidence-based proprietary OTC nutraceuticals and single molecule generic drugs with proven therapeutic benefits.

Who leads Genix Pharmaceuticals Corporation?

Mr. Mahmoud Aziz serves as the President and Director of Genix Pharmaceuticals Corporation.

How can I contact Genix Pharmaceuticals Corporation for more information?

For more information, you can reach out to Kevin Bottomley, Director, at +1.604.609.6199 or kbottomley@genixpharm.com.